ADORA2A and rheumatoid arthritis: It has been described that increased adenosine and activation of the adenosine A2A receptor inhibits both TNFα and IL1β secretion under inflammatory conditions, with an increase in IL10 [47,48], leading to anti-inflammatory effects mediated by adenosine, as occurs in RA [49].